View all available purchase options and get full access to this article.

Inconclusive electrocardiogram (ECG) or biomarker data can make it difficult to identify individuals with acute coronary syndrome who need coronary revascularization. Antonius Büscher and colleagues ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study ...

In-hospital mortality was the primary outcome. Multivariable logistic regression models were used to assess independent associations between revascularization type and outcomes. …PCI appears to be a ...

A case-based discussion navigates the decision-making process for a patient with chronic limb-threatening ischemia with poor ...

Whichever category you fall into, you can take appropriate steps to control your glucose levels before, during, and after surgery. The stress of an operation, along with potential changes in lifestyle ...

Microbot Medical Inc.’s MBOT share price has surged by 9.67%, which has investors questioning if this is right time to sell.

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial, a global ...

Microbot Medical Inc.’s MBOT share price has dipped by 5.82%, which has investors questioning if this is right time to buy.

Health care professionals should assess baseline bone mineral density in patients with osteoporosis before determining first-line therapy, researchers report. Animal testing requirements for ...

"We were probably throwing in a lot of stuff," said Folwell, who said she's scheduled for lung surgery next month. "I know WAG bags (waste-alleviating gel) with feces was going in there ...